SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001664710-21-000053
Filing Date
2021-08-05
Accepted
2021-08-05 16:08:20
Documents
60
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kros-20210630.htm   iXBRL 10-Q 1437034
2 EX-10.3 exhibit103.htm EX-10.3 106376
3 EX-31.1 exhibit311q22021.htm EX-31.1 16425
4 EX-31.2 exhibit312q22021.htm EX-31.2 16306
5 EX-32.1 exhibit321q22021.htm EX-32.1 9947
11 image_0.jpg GRAPHIC 93781
  Complete submission text file 0001664710-21-000053.txt   5051384

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kros-20210630.xsd EX-101.SCH 28509
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kros-20210630_cal.xml EX-101.CAL 48931
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kros-20210630_def.xml EX-101.DEF 111622
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kros-20210630_lab.xml EX-101.LAB 375402
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kros-20210630_pre.xml EX-101.PRE 254018
12 EXTRACTED XBRL INSTANCE DOCUMENT kros-20210630_htm.xml XML 576906
Mailing Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421 617-513-8774
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39264 | Film No.: 211148197
SIC: 2834 Pharmaceutical Preparations